Why Unfractionated Heparin Still Matters in Modern Anticoagulation – Thrombosis Canada
Thrombosis Canada shared a post on LinkedIn:
”Unfractionated heparin has been used for decades.
But using it well still requires careful clinical decisions.
When is UFH preferable to other anticoagulants?
Should treatment begin with a bolus?
When might a no – bolus strategy make more sense?
And how can the risks associated with UFH infusions be reduced?
At Thrombosis Unpacked: Decisions That Matter, Dr. Matthew Nicholson will take a modern look at this familiar anticoagulant in Unfractionated Heparin: Old Drug, Narrow Lane, focusing on where UFH still belongs in clinical practice and strategies to improve its safe use.
Join colleagues from across Canada to explore practical approaches to difficult thrombosis and anticoagulation decisions.
November 7, 2026 | Montréal.‘

Other posts featuring Thrombosis Canada on Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments